Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Bionano Genomics's peak revenue was $36.1M in 2023. The peak quarterly revenue was $8.2M in 2024(q4).
Bionano Genomics's revenue increased from $9.5m in 2017 to $30.8M currently. That's a 223.79% change in annual revenue.
| Fiscal year / year | Bionano Genomics revenue |
|---|---|
| 2017 | $9.5M |
| 2018 | $12.0M |
| 2019 | $10.1M |
| 2020 | $8.5M |
| 2021 | $18.0M |
| 2022 | $27.8M |
| 2023 | $36.1M |
| 2024 | $30.8M |
Rate Bionano Genomics' financial transparency
Bionano Genomics saw the greatest revenue growth in 2021, when revenue increased by 111.47%.
Bionano Genomics had the lowest revenue growth in 2020, when revenue changed by -16.06%.
| Year | Bionano Genomics growth |
|---|---|
| 2018 | 26%↑ |
| 2019 | -16%↓ |
| 2020 | -16%↓ |
| 2021 | 111%↑ |
| 2022 | 55%↑ |
| 2023 | 30%↑ |
| 2024 | -15%↓ |
Do you work at Bionano Genomics?
Is Bionano Genomics transparent about its revenue structure?
| CEO | R. Erik Holmlin Ph.d |
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 50 |
| Date Founded | 2003 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $30.8M |
| Net Income | -$132,596,000 |
| Gross Proft | $380,000 (2024) |
| Tax Rate | -0.0% |
| Total Assets | $307,502,000,000 |
| Ticker | BNGO |
Bionano Genomics received early financing of $5.1M on 2008-03-26.
| Series | Round size | Date |
|---|---|---|
| Series A | $5.1M | 03/2008 |
| Debt Financing | $782K | 04/2010 |
| Series B | $23.3M | 03/2011 |
| Series B | $10M | 07/2012 |
| Series C | $10M | 10/2013 |
| Debt Financing | $5M | 07/2014 |
| Series C | $53M | 11/2014 |
| Series C | $15M | 02/2015 |
| Series D | $9.9M | 03/2016 |
| Series D | $31.7M | 08/2016 |
| Investors | Security type |
|---|---|
| Battelle Ventures LP | Series A |
| 21Ventures | Series A |
| KT Venture Group | Series A |
| Battelle Ventures LP | Series B |
| KT Venture Group | Series B |
| Innovation Valley Partners | Series B |
| Domain Associates | Series B |
| Battelle Ventures LP | Series B |
| Gund Investment Corp | Series B |
| Domain Associates | Series B |
| Gund Investment Corp | Series C |
| Battelle Ventures LP | Series C |
| Domain Associates | Series C |
| Novartis Venture Fund | Series C |
| Battelle Ventures LP | Series C |
| Gund Investment Corp | Series C |
| Legend Capital | Series C |
| Domain Associates | Series C |
| Novartis Venture Fund | Series D |
| Legend Capital | Series D |
| Domain Associates | Series D |
| Novartis Venture Fund | Series D |
| LC Ventures | Series D |
| Domain Associates | Series D |
Bionano Genomics's top competitor, Illumina, earned an annual revenue of $4.4B.
Bionano Genomics's smallest competitor is Protea Biosciences Group with revenue of $2.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Illumina | - | $4.4B | 7,800 | - |
| Takara Bio Usa, Inc. | - | $95.6M | 175 | - |
| Saladax Biomedical | - | $5.2M | 28 | - |
| Protea Biosciences Group | - | $2.4M | 35 | - |
| PerkinElmer | - | $2.8B | 14,000 | - |
| Sartorius | - | $90.6M | 50 | - |
Zippia gives an in-depth look into the details of Bionano Genomics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bionano Genomics. The employee data is based on information from people who have self-reported their past or current employments at Bionano Genomics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Bionano Genomics. The data presented on this page does not represent the view of Bionano Genomics and its employees or that of Zippia.
Bionano Genomics may also be known as or be related to BIONANO GENOMICS, INC, BioNano Genomics, Inc., Bionano Genomics, Bionano Genomics Inc, Bionano Genomics, Inc and Bionano Genomics, Inc.